These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11472349)

  • 1. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.
    Noguchi T; Ikeda K; Yamamoto K; Yoshida I; Ashiba A; Tsuchiyama J; Shinagawa K; Yoshino T; Takata M; Harada M
    Br J Haematol; 2001 Jul; 114(1):84-92. PubMed ID: 11472349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense to the epstein-barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells.
    Kenney JL; Guinness ME; Curiel T; Lacy J
    Blood; 1998 Sep; 92(5):1721-7. PubMed ID: 9716601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents.
    Kenney JL; Guinness ME; Reiss M; Lacy J
    Int J Cancer; 2001 Jan; 91(1):89-98. PubMed ID: 11149426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Blood; 2006 Apr; 107(7):2928-35. PubMed ID: 16332968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMP-1 induces survivin expression to inhibit cell apoptosis through the NF-κB and PI3K/Akt signaling pathways in nasal NK/T-cell lymphoma.
    Sun L; Zhao Y; Shi H; Ma C; Wei L
    Oncol Rep; 2015 May; 33(5):2253-60. PubMed ID: 25760809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines.
    Pokrovskaja K; Ehlin-Henriksson B; Kiss C; Challa A; Gordon J; Gogolak P; Klein G; Szekely L
    Int J Cancer; 2002 Jun; 99(5):705-12. PubMed ID: 12115504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
    Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
    Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3.
    Takahara M; Kis LL; Nagy N; Liu A; Harabuchi Y; Klein G; Klein E
    Int J Cancer; 2006 Dec; 119(12):2775-83. PubMed ID: 17013900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders: A possible relation to the endemic occurrence of these diseases in Japan.
    Xu ZG; Iwatsuki K; Ohtsuka M; Oyama N; Matsui T; Kaneko F
    J Med Virol; 2000 Oct; 62(2):239-46. PubMed ID: 11002254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.
    Martin JM; Veis D; Korsmeyer SJ; Sugden B
    J Virol; 1993 Sep; 67(9):5269-78. PubMed ID: 8394449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative interaction between Bcl-2 and Epstein-Barr virus latent membrane protein 1 in the growth transformation of human epithelial cells.
    Lu JJ; Chen JY; Hsu TY; Yu WC; Su IJ; Yang CS
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():2975-85. PubMed ID: 9367385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection.
    Iwata S; Yano S; Ito Y; Ushijima Y; Gotoh K; Kawada J; Fujiwara S; Sugimoto K; Isobe Y; Nishiyama Y; Kimura H
    Int J Cancer; 2011 Nov; 129(9):2263-73. PubMed ID: 21170988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
    D'Souza B; Rowe M; Walls D
    J Virol; 2000 Jul; 74(14):6652-8. PubMed ID: 10864681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
    Röth A; Pfaff P; Lange W; Finke J
    Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
    Guinness ME; Kenney JL; Reiss M; Lacy J
    Cancer Res; 2000 Oct; 60(19):5354-8. PubMed ID: 11034070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
    Kawada J; Ito Y; Iwata S; Suzuki M; Kawano Y; Kanazawa T; Siddiquey MN; Kimura H
    Clin Cancer Res; 2014 Nov; 20(21):5412-22. PubMed ID: 25208880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A.
    Uno M; Tsuchiyama J; Moriwaki A; Noguchi T; Mizoguchi K; Ogino T; Yoshino T; Okada S; Harada M
    Br J Haematol; 2001 Jun; 113(4):1009-14. PubMed ID: 11442496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.
    Chuang HC; Lay JD; Chuang SE; Hsieh WC; Chang Y; Su IJ
    Am J Pathol; 2007 May; 170(5):1607-17. PubMed ID: 17456766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.
    Kuo TT; Shih LY; Tsang NM
    Int J Surg Pathol; 2004 Oct; 12(4):375-87. PubMed ID: 15494863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.